Chinese Firms To Dominate Domestic Cell Therapy Market As Gilead Exits

 
• By Dexter Jie Yan
  
divestment
Gilead's exit from China's cell therapy market underscores a challenging commercialization environment in the country. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia